OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
23
Results
Show all
Save search
Copy query
Show results for
Unknown
(23)
Publication Date
Release Date
2021
(4)
2015
(3)
2025
(2)
2024
(2)
2023
(2)
2022
(2)
2019
(2)
2014
(2)
2011
(2)
2017
(1)
2016
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
CD9P-1 expression correlates with the metastatic status of lung cancer, and a truncated form of CD9P-1, GS-168AT2, inhibits in vivo tumour growth.
Not available
S-EPMC3049554
|
biostudies-literature
Cite
A truncated form of CD9-partner 1 (CD9P-1), GS-168AT2, potently inhibits in vivo tumour-induced angiogenesis and tumour growth.
Not available
S-EPMC3185932
|
biostudies-literature
Cite
Tumor cells with neuronal intermediate progenitor features define a subgroup of 1p/19q co-deleted anaplastic gliomas.
Not available
S-EPMC8029323
|
biostudies-literature
Cite
Mitotic index, microvascular proliferation, and necrosis define 3 groups of 1p/19q codeleted anaplastic oligodendrogliomas associated with different genomic alterations.
Not available
S-EPMC4136899
|
biostudies-literature
Cite
Integrated multi-omics analysis of oligodendroglial tumours identifies three subgroups of 1p/19q co-deleted gliomas.
Not available
S-EPMC4838899
|
biostudies-literature
Cite
Prenatal diagnosis by trio exome sequencing in fetuses with ultrasound anomalies: A powerful diagnostic tool.
Not available
S-EPMC10076577
|
biostudies-literature
Cite
The level of activity of the alternative lengthening of telomeres correlates with patient age in IDH-mutant ATRX-loss-of-expression anaplastic astrocytomas.
Not available
S-EPMC6842523
|
biostudies-literature
Cite
Prognostic Relevance of Histomolecular Classification of Diffuse Adult High-Grade Gliomas with Necrosis.
Not available
S-EPMC8029113
|
biostudies-literature
Cite
Classification of GBA1 variants and their impact on Parkinson's disease: an in silico score analysis.
Not available
S-EPMC12318041
|
biostudies-literature
Cite
CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas.
Not available
S-EPMC7145561
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets